Nanobiotix NBTX
$26.50 −$0.82 (-2.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.50 0.00%
Open$28.15
Prev close$27.32
Day range$26.12 – $28.60
Volume125.3K
Market cap$1.35B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±6.4%last 13 reports
Closed higher5 of 1338% of the time
Best reaction+10.4%
Worst reaction-40.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2025/Q4 | 31 Mar 2026 | After Market | – | +10.37% | – |
| 2024/Q4 | 2 Apr 2025 | None | – | -0.59% | – |
| 2024/Q1 | 22 May 2024 | None | – | +6.27% | – |
| 2023/Q4 | 24 Apr 2024 | None | – | +0.17% | – |
| 2023/Q3 | 13 Nov 2023 | After Market | – | -1.03% | – |
| 2023/Q2 | 26 Sep 2023 | After Market | – | -1.52% | – |
| 2022/Q4 | 24 Apr 2023 | After Market | – | -39.95% | – |
| 2022/Q3 | 9 Nov 2022 | None | – | +0.00% | – |
| 2022/Q2 | 28 Sep 2022 | None | – | -6.41% | – |
| 2022/Q1 | 18 May 2022 | None | – | +6.59% | – |
| 2021/Q4 | 30 Mar 2022 | None | – | +3.91% | – |
| 2021/Q2 | 8 Sep 2021 | None | – | -2.55% | – |
| 2020/Q4 | 17 Mar 2021 | None | – | -4.20% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2025/FY
By business line
Fundamentals
Latest reported quarter: ANNUAL, ended Dec 2025 · reported in EUR
Revenue€29.64M+355.3% YoY
Operating profit-€10.82M+84.2% YoY
Net profit-€23.96M+64.8% YoY
Diluted EPS-€0.50+65.3% YoY
Profitability & balance sheet
Operating margin-353.6%
Net margin-632.5%
Return on assets-60.9%
Current ratio1.44
Liabilities / assets126.0%
Cash & investments€110.89M
Total debt€105.38M
Net cash (debt)€5.51M
No comments yet — be the first to weigh in on NBTX.
Sign in to join the discussion.